164 related articles for article (PubMed ID: 37731222)
1. Weight-independent effects of Roux-en-Y gastric bypass surgery on remission of nonalcoholic fatty liver disease in mice.
Axelrod CL; Langohr I; Dantas WS; Heintz EC; Vandanmagsar B; Yang S; Zunica ERM; Townsend RL; Albaugh VL; Berthoud HR; Kirwan JP
Obesity (Silver Spring); 2023 Dec; 31(12):2960-2971. PubMed ID: 37731222
[TBL] [Abstract][Full Text] [Related]
2. Roux-en-Y gastric bypass induces hepatic transcriptomic signatures and plasma metabolite changes indicative of improved cholesterol homeostasis.
Lalloyer F; Mogilenko DA; Verrijken A; Haas JT; Lamazière A; Kouach M; Descat A; Caron S; Vallez E; Derudas B; Gheeraert C; Baugé E; Despres G; Dirinck E; Tailleux A; Dombrowicz D; Van Gaal L; Eeckhoute J; Lefebvre P; Goossens JF; Francque S; Staels B
J Hepatol; 2023 Oct; 79(4):898-909. PubMed ID: 37230231
[TBL] [Abstract][Full Text] [Related]
3. Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice.
Li K; Zou J; Li S; Guo J; Shi W; Wang B; Han X; Zhang H; Zhang P; Miao Z; Li Y
Mol Metab; 2020 Jul; 37():100980. PubMed ID: 32305491
[TBL] [Abstract][Full Text] [Related]
4. Roux-en-Y Gastric Bypass Surgery-Induced Weight Loss and Metabolic Improvements Are Similar in TGR5-Deficient and Wildtype Mice.
Hao Z; Leigh Townsend R; Mumphrey MB; Gettys TW; Yu S; Münzberg H; Morrison CD; Berthoud HR
Obes Surg; 2018 Oct; 28(10):3227-3236. PubMed ID: 29770924
[TBL] [Abstract][Full Text] [Related]
5. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy and lactation after Roux-en-Y gastric bypass worsen nonalcoholic fatty liver disease in obese rats and lead to differential programming of hepatic
Bertasso IM; Pietrobon CB; Ribeiro RA; Soares GM; Oliveira JC; Alegre-Maller ACP; Boschero AC; Araújo ACF; Guimarães ATB; Bonfleur ML; Balbo SL
J Dev Orig Health Dis; 2022 Apr; 13(2):263-273. PubMed ID: 33998431
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Diet Composition on the Post-operative Outcomes of Roux-en-Y Gastric Bypass in Mice.
Stevenson M; Srivastava A; Nacher M; Hall C; Palaia T; Lee J; Zhao CL; Lau R; Ali MAE; Park CY; Schlamp F; Heffron SP; Fisher EA; Brathwaite C; Ragolia L
Obes Surg; 2024 Mar; 34(3):911-927. PubMed ID: 38191966
[TBL] [Abstract][Full Text] [Related]
8. Body Composition, Food Intake, and Energy Expenditure in a Murine Model of Roux-en-Y Gastric Bypass Surgery.
Hao Z; Mumphrey MB; Townsend RL; Morrison CD; Münzberg H; Ye J; Berthoud HR
Obes Surg; 2016 Sep; 26(9):2173-2182. PubMed ID: 26781597
[TBL] [Abstract][Full Text] [Related]
9. Gastric bypass surgery is protective from high-fat diet-induced non-alcoholic fatty liver disease and hepatic endoplasmic reticulum stress.
Mosinski JD; Pagadala MR; Mulya A; Huang H; Dan O; Shimizu H; Batayyah E; Pai RK; Schauer PR; Brethauer SA; Kirwan JP
Acta Physiol (Oxf); 2016 Jun; 217(2):141-51. PubMed ID: 26663034
[TBL] [Abstract][Full Text] [Related]
10. Roux-en-Y Gastric Bypass Surgery Suppresses Hepatic Gluconeogenesis and Increases Intestinal Gluconeogenesis in a T2DM Rat Model.
Yan Y; Zhou Z; Kong F; Feng S; Li X; Sha Y; Zhang G; Liu H; Zhang H; Wang S; Hu C; Zhang X
Obes Surg; 2016 Nov; 26(11):2683-2690. PubMed ID: 27038047
[TBL] [Abstract][Full Text] [Related]
11. Development and verification of a mouse model for Roux-en-Y gastric bypass surgery with a small gastric pouch.
Hao Z; Zhao Z; Berthoud HR; Ye J
PLoS One; 2013; 8(1):e52922. PubMed ID: 23326365
[TBL] [Abstract][Full Text] [Related]
12. Roux-en-Y gastric bypass restores islet function and morphology independent of body weight in ZDF rats.
Mosinski JD; Aminian A; Axelrod CL; Batayyah E; Romero-Talamas H; Daigle C; Mulya A; Scelsi A; Schauer PR; Brethauer SA; Kirwan JP
Am J Physiol Endocrinol Metab; 2021 Feb; 320(2):E392-E398. PubMed ID: 33427046
[TBL] [Abstract][Full Text] [Related]
13. Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity.
Angelini G; Castagneto-Gissey L; Casella-Mariolo J; Caristo ME; Russo MF; Lembo E; Verrastro O; Stefanizzi G; Marini PL; Casella G; Bornstein SR; Rubino F; Mingrone G
Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G502-G511. PubMed ID: 32812775
[TBL] [Abstract][Full Text] [Related]
14. Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.
Cherla DV; Rodriguez NA; Vangoitsenhoven R; Singh T; Mehta N; McCullough AJ; Brethauer SA; Schauer PR; Aminian A
Surg Endosc; 2020 May; 34(5):2266-2272. PubMed ID: 31359195
[TBL] [Abstract][Full Text] [Related]
15. Reversal of NAFLD After VSG Is Independent of Weight-Loss but RYGB Offers More Efficacy When Maintained on a High-Fat Diet.
Srivastava A; Stevenson M; Lee J; Hall C; Palaia T; Zhao CL; Lau R; Brathwaite C; Ragolia L
Obes Surg; 2022 Jun; 32(6):2010-2022. PubMed ID: 35419698
[TBL] [Abstract][Full Text] [Related]
16. Gastric Bypass Increases Circulating Bile Acids and Activates Hepatic Farnesoid X Receptor (FXR) but Requires Intact Peroxisome Proliferator Activator Receptor Alpha (PPARα) Signaling to Significantly Reduce Liver Fat Content.
Mazzini GS; Khoraki J; Browning MG; Wu J; Zhou H; Price ET; Wolfe LG; Mangino MJ; Campos GM
J Gastrointest Surg; 2021 Apr; 25(4):871-879. PubMed ID: 33555523
[TBL] [Abstract][Full Text] [Related]
17. Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis.
Verbeek J; Lannoo M; Pirinen E; Ryu D; Spincemaille P; Vander Elst I; Windmolders P; Thevissen K; Cammue BP; van Pelt J; Fransis S; Van Eyken P; Ceuterick-De Groote C; Van Veldhoven PP; Bedossa P; Nevens F; Auwerx J; Cassiman D
Gut; 2015 Apr; 64(4):673-83. PubMed ID: 24917551
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic fatty liver disease and gastric bypass surgery regulate serum and hepatic levels of pyruvate kinase isoenzyme M2.
Meoli L; Gupta NK; Saeidi N; Panciotti CA; Biddinger SB; Corey KE; Stylopoulos N
Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E613-E621. PubMed ID: 29462566
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal assessment of food intake, fecal energy loss, and energy expenditure after Roux-en-Y gastric bypass surgery in high-fat-fed obese rats.
Shin AC; Zheng H; Townsend RL; Patterson LM; Holmes GM; Berthoud HR
Obes Surg; 2013 Apr; 23(4):531-40. PubMed ID: 23269513
[TBL] [Abstract][Full Text] [Related]
20. Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device.
Casella-Mariolo J; Castagneto-Gissey L; Angelini G; Zoli A; Marini P; Bornstein SR; Pournaras DJ; Rubino F; le Roux CW; Mingrone G; Casella G
EBioMedicine; 2019 Aug; 46():452-462. PubMed ID: 31401193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
